Efficacy Outcomes in the Phase 3 COMBI-AD Study of Adjuvant Dabrafenib Plus Trametinib vs Placebo in Patients with Stage III BRAFV600E/K-Mutant Melanoma

Georgina V. Long, John M. Kirkwood, Reinhard Drummer et al.|SKIN The Journal of Cutaneous Medicine|2018

Cited by 1